<b>Results:</b><i>IRX3</i> and <i>IRX5</i> were consistently elevated in estrogen-dependent tumours and <i>IRX</i>2 and <i>IRX</i>4 were notably upregulated in prostate cancer. This evidence concerns the gene IRX5 and prostate carcinoma.